BioCryst Pharmaceuticals ... (BCRX)

NASDAQ: BCRX · Real-Time Price · USD

8.72

-0.13 (-1.47%)

At close: May 01, 2025, 3:59 PM

8.61

-1.26%

After-hours: May 01, 2025, 07:49 PM EDT

BioCryst Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	450.71M	331.41M	270.83M	157.17M	17.81M	48.84M	20.65M	25.19M	26.35M
Cost of Revenue	12.27M	4.66M	6.59M	7.26M	1.68M	4.1M	471K	1.7M	2.7M
Gross Profit	438.44M	326.75M	264.23M	149.91M	16.14M	44.73M	20.18M	23.48M	23.65M
Operating Income	-2.54M	-103.71M	-148.44M	-177.72M	-174.76M	-99.45M	-94.22M	-57.41M	-48.61M
Interest Income	14.75M	15.78M	5.13M	62K	9.42M	1.93M	2.25M	1.01M	793K
Pretax Income	-86.95M	-226.23M	-244.38M	-181.81M	-182.81M	-108.9M	-101.25M	-65.78M	-55.14M
Net Income	-88.88M	-226.54M	-247.12M	-184.06M	-196.57M	-120.06M	-101.25M	-65.78M	-55.14M
Selling & General & Admin	266.13M	213.89M	159.37M	118.82M	67.93M	37.12M	29.51M	13.93M	11.25M
Research & Development	174.64M	216.57M	253.3M	208.81M	122.96M	107.07M	84.89M	66.96M	61.01M
Other Expenses	216K	n/a	253.27M	202.92M	111.96M	82.44M	70.81M	54.38M	47.01M
Operating Expenses	440.99M	430.46M	412.67M	327.63M	190.89M	144.19M	114.4M	80.89M	72.26M
Interest Expense	98.52M	108.24M	99.09M	59.29M	14.5M	11.89M	9.18M	8.56M	6.49M
Selling & Marketing Expenses	n/a	14.4M	14.89M	5.71M	6.57M	n/a	n/a	n/a	n/a
Cost & Expenses	453.25M	435.12M	419.26M	334.89M	192.57M	148.29M	114.87M	82.6M	74.96M
Income Tax Expense	1.93M	310K	2.73M	2.25M	13.75M	11.17M	2.14M	7.86M	6M
Shares Outstanding (Basic)	206.7M	192.2M	185.91M	179.12M	167.27M	115.6M	103.19M	84.45M	73.7M
Shares Outstanding (Diluted)	206.7M	192.2M	185.91M	179.12M	167.27M	115.6M	103.19M	84.45M	73.7M
EPS (Basic)	-0.43	-1.18	-1.33	-1.03	-1.18	-1.04	-0.98	-0.78	-0.75
EPS (Diluted)	-0.43	-1.18	-1.33	-1.03	-1.18	-1.04	-0.98	-0.78	-0.75
EBITDA	12.81M	-116.33M	-143.85M	-121.74M	-167.56M	-96.28M	-90.36M	-56.51M	-48.17M
EBIT	11.56M	-117.99M	-145.29M	-122.52M	-168.31M	-97M	-92.08M	-57.22M	-48.66M
Depreciation & Amortization	1.25M	1.66M	1.44M	777K	748K	724K	770K	704K	483K